Human Genome Epidemiology Literature Finder
Records 1 - 10 (of 10 Records) |
Query Trace: Coronary artery disease and ABCG2[original query] |
---|
A polymorphism in the protease-like domain of apolipoprotein(a) is associated with severe coronary artery disease. Arteriosclerosis, thrombosis, and vascular biology 2007 Sep 27 (9): 2030-6. Luke May M, Kane John P, Liu Dongming M, Rowland Charles M, Shiffman Dov, Cassano June, Catanese Joseph J, Pullinger Clive R, Leong Diane U, Arellano Andre R, Tong Carmen H, Movsesyan Irina, Naya-Vigne Josephina, Noordhof Curtis, Feric Nicole T, Malloy Mary J, Topol Eric J, Koschinsky Marlys L, Devlin James J, Ellis Stephen |
Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease. PloS one 2009 4 (11): e7729. Stark Klaus, Reinhard Wibke, Grassl Martina, Erdmann Jeanette, Schunkert Heribert, Illig Thomas, Hengstenberg Christi |
Genetic impact on uric acid concentration and hyperuricemia in the Japanese population. Journal of atherosclerosis and thrombosis 2012 Dec . Takeuchi F, Yamamoto K, Isono M, Katsuya T, Akiyama K, Ohnaka K, Rakugi H, Yamori Y, Ogihara T, Takayanagi R, Kato N |
Simvastatin intolerance genetic determinants: some features in ethnic Uzbek patients with coronary artery disease. Archives of medical sciences. Atherosclerotic diseases 2017 2 e68-e75. Shek Aleksandr B, Kurbanov Ravshanbek D, Abdullaeva Guzal J, Nagay Aleksandr V, Hoshimov Shavkat U, Nizamov Ulugbek I, Ziyaeva Adolat V, Alieva Rano |
Effects of SLCO1B1 and GATM gene variants on rosuvastatin-induced myopathy are unrelated to high plasma exposure of rosuvastatin and its metabolites. Acta pharmacologica Sinica 2018 Jun . Bai Xue, Zhang Bin, Wang Ping, Wang Guan-Lei, Li Jia-Li, Wen Ding-Sheng, Long Xing-Zhen, Sun Hong-Shuo, Liu Yi-Bin, Huang Min, Zhong Shi-Lo |
Genetic contributors to serum uric acid levels in Mexicans and their effect on premature coronary artery disease.
![]() International journal of cardiology 2018 Oct . Macias-Kauffer Luis R, Villamil-Ramírez Hugo, León-Mimila Paola, Jacobo-Albavera Leonor, Posadas-Romero Carlos, Posadas-Sánchez Rosalinda, López-Contreras Blanca E, Morán-Ramos Sofía, Romero-Hidalgo Sandra, Acuña-Alonzo Víctor, Del-Río-Navarro Blanca E, Bortolini Maria-Cátira, Gallo Carla, Bedoya Gabriel, Rothhammer Francisco, González-Jose Rolando, Ruiz-Linares Andrés, Stephens Christopher R, Velazquez-Cruz Rafael, Fernández Del Valle-Laisequilla Cecilia, Reyes-García Juan G, Barranco Garduño Lina M, Carrasco-Portugal Miriam Del C, Flores-Murrieta Francisco J, Vargas-Alarcón Gilberto, Aguilar-Salinas Carlos A, Villarreal-Molina Teresa, Canizales-Quinteros Samu |
Personalized rosuvastatin therapy in problem patients with partial statin intolerance. Archives of medical sciences. Atherosclerotic diseases 2018 3 e83-e89. Shek Aleksandr B, Kurbanov Ravshanbek D, Alieva Rano B, Abdullaeva Guzal J, Nagay Aleksandr V, Abdullaev Alisher A, Hoshimov Shavkat U, Nizamov Ulugbek |
Effects of genetic and nongenetic factors on hyperuricemia in Chinese patients with coronary artery disease. Pharmacogenomics 2021 9 22 (13): 821-831. Zhang Weixia, Jin Yiwen, Li Juan, Huang Jingjing, Chen Hefe |
Pharmacogenetic loci for rosuvastatin are associated with intima-media thickness change and coronary artery disease risk. Pharmacogenomics 2021 12 23 (1): 15-34. Kononov Stanislav, Mal Galina, Azarova Iuliia, Klyosova Elena, Bykanova Marina, Churnosov Mikhail, Polonikov Alex |
Association of the ABCG2 rs2231142 variant with the Framingham Cardiovascular Disease Risk score in the Taiwanese population. Heliyon 2024 9 10 (18): e37839. Chun-Kang Lee, I-Chieh Chen, Hsueh-Ju Lin, Ching-Heng Lin, Yi-Ming Ch |
- Page last reviewed:Feb 1, 2024
- Content source: